NRx Pharmaceuticals, Inc. (NRXP) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.36M | 8.89M | 11.95M | 4.59M | 7.26M | 3.3M | 4.11M | 4.88M | 3.35M | 6.88M | 13.09M | 19.79M | 21.76M | 25.8M | 24.8M | 32.41M | 43.58M | 32.71M | 45.23M | 18.53M |
| Cash & Short-Term Investments | 6.71M | 7.8M | 7.18M | 2.91M | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.59M | 8.9M | 14.97M | 16.51M | 20.05M | 18.25M | 24.55M | 40.2M | 27.61M | 38.88M | 13.39M |
| Cash Only | 6.71M | 7.8M | 7.18M | 2.91M | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.59M | 8.9M | 14.97M | 16.51M | 20.05M | 18.25M | 24.55M | 40.2M | 27.61M | 38.88M | 13.39M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 181K | 161K | 239K | 0 | 0 | 0 | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 7K | 547K | 554K | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 14.41 | 18.72 | 90.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 4.52M | 0 | 0 | 0 | 0 | 0 | 128K | 0 | 0 | 0 | 0 | 5.73M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 4.54M | 4.06M | 3.05M | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K |
| Property, Plant & Equipment | 936K | 696K | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 1.31x | 1.88x | 0.69x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 1.79M | 1.79M | 610K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 879K | 925K | 1.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 399K | 397K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 535K | 253K | 312K | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K |
| Total Assets | 11.9M | 12.96M | 15M | 4.84M | 7.59M | 3.65M | 4.46M | 5.26M | 3.79M | 7.32M | 13.11M | 19.81M | 21.78M | 25.82M | 24.82M | 32.43M | 43.6M | 32.73M | 45.25M | 18.55M |
| Asset Turnover | 0.09x | 0.07x | 0.02x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 56.82% | 254.86% | 236.08% | -8.09% | 100.37% | -50.09% | -65.96% | -73.43% | -82.61% | -71.66% | -47.19% | -38.92% | -50.05% | -21.12% | -45.14% | 74.87% | 623.34% | 1012.85% | 650.2% | 195.47% |
| Total Current Liabilities | 25.18M | 28.58M | 40.59M | 40.45M | 32.75M | 21.86M | 20.3M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 15.59M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.47M |
| Accounts Payable | 4.4M | 4.27M | 4.26M | 3.63M | 4.31M | 4.13M | 4.87M | 5.01M | 6.26M | 4.63M | 3.63M | 2.21M | 3.78M | 2.08M | 2.17M | 3.08M | 4.31M | 3.69M | 5.56M | 6.27M |
| Days Payables Outstanding | 490.08 | 772.13 | 2.63K | - | - | 413.82K | 227.26K | 513.24K | 495.81K | 380.1K | 134.23K | 272.14K | 263.34K | 195.22K | 241.32K | 336.2K | 359.91K | 1000K | 852.78K | 589.88K |
| Short-Term Debt | 391K | 316K | 189K | 10.23M | 8.4M | 1.57M | 3.68M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 7.7M | 0 | 0 | 520K | 518K | 515.06K | 173.69K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.39M | 23.5M | 36.15M | 21.42M | 15.12M | 10.93M | 11.35M | 9.6M | 26K | 4.42M | 10K | 36K | 25K | 5.81M | 56K | 19K | 2.61M | 4.87M | 27.06M | 26.39M |
| Current Ratio | 0.29x | 0.31x | 0.29x | 0.11x | 0.22x | 0.15x | 0.20x | 0.21x | 0.18x | 0.36x | 0.68x | 0.87x | 0.99x | 1.66x | 3.08x | 4.58x | 3.66x | 2.74x | 1.25x | 0.52x |
| Quick Ratio | 0.29x | 0.31x | 0.29x | 0.11x | 0.22x | 0.15x | 0.20x | 0.21x | 0.18x | 0.36x | 0.68x | 0.87x | 0.99x | 1.66x | 3.08x | 4.58x | 3.66x | 2.74x | 1.25x | 0.52x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 543K | 315K | 158K | 0 | 0 | 5.01M | 2.98M | 0 | 0 | 0 | 0 | 0 | 0 | 2.82M | 0 | 0 | 0 | 0 | 0 | 512.47K |
| Long-Term Debt | 543K | 0 | 158K | 0 | 0 | 5.01M | 2.98M | 0 | 0 | 0 | 0 | 0 | 0 | 2.82M | 0 | 0 | 0 | 0 | 0 | 512.47K |
| Capital Lease Obligations | 0 | 315K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 25.72M | 28.89M | 40.75M | 40.45M | 32.75M | 26.87M | 23.28M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 18.41M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.98M |
| Total Debt | 934K | 631K | 347K | 10.23M | 8.4M | 6.58M | 6.67M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 10.53M | 0 | 0 | 520K | 518K | 515.06K | 686.17K |
| Net Debt | -5.78M | -7.17M | -6.84M | 7.32M | 2.85M | 5.13M | 5.02M | 6.7M | 5.46M | 4.57M | 1.17M | -2.28M | -4.32M | -9.53M | -18.25M | -24.55M | -39.68M | -27.09M | -38.37M | -12.7M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.42x | - | - | 0.02x | 0.02x | 0.06x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -20.38x | -6.85x | - | - | - | - | - | -8.30x | -27.38x | -53.15x | -150.55x | - | - | - | - | - | -4481.67x | -13135.97x | -6900.89x | -22.03x |
| Total Equity | -13.82M | -15.94M | -25.75M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M | -284K | 7.41M | 16.78M | 25.35M | 31.69M | 20.81M | 8.97M | -17.44M |
| Equity Growth % | 45.09% | 31.37% | -36.83% | -93.65% | -66.97% | -97.93% | -202.75% | -554.95% | -5205.99% | -258.36% | -137.05% | -111.08% | -100.9% | -64.39% | 87.14% | 245.39% | 2497.37% | 147.53% | 180.13% | -580.87% |
| Book Value per Share | -0.43 | -0.50 | -1.16 | -1.99 | -1.53 | -2.21 | -1.72 | -1.75 | -1.70 | -0.14 | -0.76 | -0.04 | -0.00 | 0.11 | 0.25 | 0.39 | 0.50 | 0.40 | 0.16 | -0.41 |
| Total Shareholders' Equity | -13.82M | -15.94M | -25.75M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M | -284K | 7.41M | 16.78M | 25.35M | 31.69M | 20.81M | 8.97M | -17.44M |
| Common Stock | 33K | 32K | 28K | 19K | 17K | 15K | 11K | 11K | 10K | 84K | 84K | 80K | 70K | 67K | 68K | 67K | 67K | 59K | 54.81K | 48.6K |
| Retained Earnings | -308.32M | -306.89M | -307.26M | -301.37M | -283.79M | -278.27M | -269.19M | -267.57M | -259.68M | -253.15M | -248.81M | -242.75M | -234.04M | -223M | -212.76M | -203.67M | -196.69M | -183.24M | -152.45M | -131.68M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3K | -3K | -3K | -22K | -22K | 106K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |